Focal epilepsies in adult patients attending two epilepsy centers: Classification of drug‐resistance, assessment of risk factors, and usefulness of “new” antiepileptic drugs
Isabella Gilioli(Fondazione IRCCS Istituto Neurologico Carlo Besta), S. Binelli(Fondazione IRCCS Istituto Neurologico Carlo Besta), Elena Gardella(University of Southern Denmark), Francesca La Briola(University of Milan), Aglaia Vignoli(University of Milan), Laura Canafoglia(Fondazione IRCCS Istituto Neurologico Carlo Besta), Silvana Franceschetti(Fondazione IRCCS Istituto Neurologico Carlo Besta), Marina Casazza(University of Tübingen), Valentina Chiesa(Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo), Elisa Visani(Fondazione IRCCS Istituto Neurologico Carlo Besta), Ferruccio Panzica(Fondazione IRCCS Istituto Neurologico Carlo Besta), G. Avanzini(Fondazione IRCCS Istituto Neurologico Carlo Besta), Maria Paola Canevini(University of Milan)
Cited by 52
Related Papers
The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission1
|Epilepsia|2010|1.7k
Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery
|New England Journal of Medicine|2017|916
Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry
|The Lancet Neurology|2018|537
International Consensus Based Review and Recommendations for Minimum Reporting Standards in Research on Transcutaneous Vagus Nerve Stimulation (Version 2020)
|Frontiers in Human Neuroscience|2021|335
Mutations in NHLRC1 cause progressive myoclonus epilepsy
|Nature Genetics|2003|330